Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma |
University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD |
Young Investigator Grants |
2014 |
Hawaii |
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan / Carl Koschmann, MD |
Young Investigator Grants |
2014 |
Michigan |
Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells |
Dana-Farber Cancer Institute / Zhaodong Li, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
SETD2 Mutations in Prognosis and Chemotherapy Resistance in Relapsed Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Brenton Mar, MD, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Ca2+ Release Activated Ca2+ (CRAC) Channels in Control of Leukemic Cell Metabolism and Leukemia Stem Cell Maintenance in T-ALL |
New York University School of Medicine / Mate Maus, PhD |
Young Investigator Grants |
2014 |
New York |
Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells |
Children's Hospital of Philadelphia / Mitchell Weiss, M.D., Ph.D. |
Innovation Grants |
2014 |
Pennsylvania |
Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas |
University of Colorado Denver / Heide Ford, Ph.D. |
Innovation Grants |
2014 |
Colorado |
Targeting eEF2 Kinase in Neuroblastoma |
University of California San Francisco / William Weiss, M.D., Ph.D. |
Innovation Grants |
2014 |
California |
Converting the Glioblastoma Multiforme Tumor-Associated Macrophage Phenotype |
The Johns Hopkins University School of Medicine / Alan D. Friedman, M.D. |
Innovation Grants |
2014 |
Maryland |
Targeting MYC/MYCN-driven Transcriptional Amplification in Pediatric Cancer |
Dana-Farber Cancer Institute / Rani George, M.D., Ph.D. |
Innovation Grants |
2014 |
Massachusetts |